NB cell viability decreased, increased phagocytosis in NB-EbC1 cells, and increased immunogenic cell death;Decreased tumor growth in 72% of mice and increased survival rate after the vaccination of A/J mice with NXS2-GPC2 cells treated with ADC. Here, GPC2 is linked to neoplasm.